{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:59:43Z","timestamp":1758052783263,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.clinbiochem.2013.12.006","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T13:30:27Z","timestamp":1387287027000},"page":"356-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The association between Factor V Leiden with the presence and severity of coronary artery disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Mohammadali","family":"Boroumand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"pourgholi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Sotoudeh","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Goodarzynejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0020","first-page":"535","article-title":"Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India","volume":"57","author":"Gupta","year":"2003","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.carpath.2012.03.002","article-title":"Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction","volume":"22","author":"Berredjeb Ben Slama","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0030","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","article-title":"Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women","volume":"89","author":"Rosendaal","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(00)00772-5","article-title":"Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50years with no significant stenoses at angiography three to four weeks after myocardial infarction","volume":"36","author":"Van de Water","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","article-title":"Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A","volume":"97","author":"Doggen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0055","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.clinbiochem.2009.01.005","article-title":"Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography","volume":"42","author":"Boroumand","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-012-0772-0","article-title":"Polymorphisms in Factor II and Factor V thrombophilia genes among Circassians in Jordan","volume":"35","author":"Dajani","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MBC.0b013e3281139c55","article-title":"Association between factor V Leiden mutation and coronary artery disease in the northeast region of Turkey","volume":"18","author":"Gurlertop","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2005.04.002","article-title":"Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics","volume":"86","author":"Bauduer","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11239-007-0052-6","article-title":"Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran","volume":"25","author":"Rahimi","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0037-1613816","article-title":"Thrombophilic mutations in Iran","volume":"83","author":"Zeinali","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MBC.0b013e3283255487","article-title":"Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran","volume":"20","author":"Rahimi","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2002-01-0111","article-title":"Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses","volume":"100","author":"Juul","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0049-3848(98)00076-0","article-title":"Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease","volume":"91","author":"Dunn","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(95)90310-0","article-title":"Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance","volume":"345","author":"Emmerich","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1018652429633","article-title":"Incidence of factor V Leiden in patients with acute myocardial infarction","volume":"9","author":"Gowda","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0037-1614444","article-title":"The factor II G20210A and factor V G1691A gene transitions and coronary heart disease","volume":"81","author":"Gardemann","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0125","first-page":"242","article-title":"Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction","volume":"1","author":"Baykan","year":"2001","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1590\/S1415-47572008005000023","article-title":"MTHFR, prothrombin and Factor V gene variants in Turkish patients with coronary artery stenosis","volume":"31","author":"Caner","year":"2008","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ihj.2012.07.006","article-title":"Factor V Leiden mutation is not a predisposing factor for acute coronary syndromes","volume":"64","author":"Himabindu","year":"2012","journal-title":"Indian Heart J"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:THRO.0000040489.86029.27","article-title":"Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease","volume":"17","author":"Almawi","year":"2004","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.ATV.0000107402.79771.fc","article-title":"Genetic determinants of arterial thrombosis","volume":"24","author":"Voetsch","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0895-7061(99)00140-5","article-title":"Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension","volume":"13","author":"Makris","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0155","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(95)90626-6","article-title":"Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease","volume":"345","author":"Marz","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0160","first-page":"424","article-title":"The effects of factor V Leiden, prothrombin G20210A, MTHFR C677T, MTHFR A1298C, factor XIIIA Val34Leu, factor XIIIB His95Arg and apolipoprotein E genotypes on coronary artery disease","volume":"37","author":"Yenilmez","year":"2012","journal-title":"T\u00fcrk Biyokim Derg"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0165","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2010.03982.x","article-title":"The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease","volume":"8","author":"Mannucci","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1479-5876-10-235","article-title":"Prothrombotic gene variants as risk factors of acute myocardial infarction in young women","volume":"10","author":"Tomaiuolo","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MCA.0b013e32832bdb8c","article-title":"The factor V G1691A, factor V H1299R, prothrombin G20210A polymorphisms in children with family history of premature coronary artery disease","volume":"20","author":"Ciftdogan","year":"2009","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0180","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1126\/science.8091226","article-title":"Genetic dissection of complex traits","volume":"265","author":"Lander","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0185","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.0000160854.75779.E8","article-title":"Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice","volume":"111","author":"Eitzman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0190","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1073\/pnas.95.21.12591","article-title":"Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice","volume":"95","author":"Lou","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2013.12.006_bb0195","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI1461","article-title":"Fibrinogen deficiency is compatible with the development of atherosclerosis in mice","volume":"101","author":"Xiao","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013005912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013005912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:44:11Z","timestamp":1757864651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013005912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0009912013005912"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between Factor V Leiden with the presence and severity of coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}